MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 148 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,195 | -32.1% | 8,000 | 0.0% | 0.00% | -25.0% |
| Q2 2023 | $1,761 | +30.5% | 8,000 | +37.9% | 0.00% | +33.3% |
| Q1 2023 | $1,349 | -21.0% | 5,800 | 0.0% | 0.00% | -40.0% |
| Q4 2022 | $1,708 | -99.9% | 5,800 | -77.5% | 0.01% | -28.6% |
| Q2 2021 | $2,489,000 | +58.2% | 25,750 | +87.3% | 0.01% | +40.0% |
| Q1 2021 | $1,573,000 | +205.4% | 13,750 | +189.5% | 0.01% | +150.0% |
| Q4 2020 | $515,000 | -63.1% | 4,750 | -18.8% | 0.00% | -75.0% |
| Q1 2019 | $1,395,000 | 0.0% | 5,850 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,395,000 | -16.4% | 5,850 | -2.5% | 0.01% | -27.3% |
| Q2 2018 | $1,668,000 | – | 6,000 | +299900.0% | 0.01% | – |
| Q4 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 2 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 2 | -50.0% | 0.00% | – |
| Q3 2016 | $0 | – | 4 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |